click below
click below
Normal Size Small Size show me how
Spring '26 BDK 8
ID 3-4, Pain/Heme/Onc 1-3
| Pharmacologic Category | Generic Name | Brand Name | Classification | Common Indication |
|---|---|---|---|---|
| Lincosamide antibiotic | clindamycin (PO,IV) | Cleosin | SSTI, pharyngitis Activity against: MRSA | |
| Sulfonamide antibiotic | sulfamethoxazole and trimethoprim (PO,IV) | Bactrim, Bactrim DS | SSTI, cystitis, pyelonephritis, opportunistic infection prophylaxis Activity against: MRSA, Enterobacteriaceae | |
| Urinary antibiotic | nitrofurantoin (PO) | Macrobid | Cystitis Activity against: Escherichia coli | |
| Urinary antibiotic | fosfomycin (PO) | Monurol | Cystitis Activity against: Escherichia coli | |
| Aminoglycoside antibiotic | tobramycin (IV, inhaled) | Tobi (inhaled) | HAP, cystic fibrosis (nebulized only) Activity against: Escherichia coli, Pseudomonas aeruginosa | |
| Glycopeptide antibiotic | vancomycin (IV, PO) | Vancosin | IV: SSTI, HAP, meningitis, endocarditis, CRBSI PO: CDI Activity against: MRSA, Clostridioides difficile (PO only) | |
| Antibiotic | metronidazole (PO, IV) | Flagyl | Anaerobic infections, CDI Activity against: Bacteroides species, Clostridioides difficile | |
| Antibiotic | mupirocin (topical) | Bactroban | MRSA decolonization | |
| Topical antibiotic | neomycin + polymyxin B + bacitracin (topical, ophthalmic) | Topical: Neosporin Ophthalmic: Neo-Polycin | Neosporin: OTC | Topical infection prevention Ocular infections |
| Allylamine antifungal | terbinafine (PO, topical) | Lamisil | Topical: OTC | Onychomycosis |
| Azole antifungal | fluconazole (PO, IV) | Diflucan | Vulvovaginal candidiasis, oropharyngeal candidiasis, invasive candidiasis | |
| Azole antifungal | ketoconazole (PO, topical) | Nizoral | Topical: OTC | Tinea infections |
| Polyene antifungal | nystatin (PO) | --- | Oropharyngeal candidiasis | |
| Polyene antifungal | nystatin (topical) | Nystop | Cutaneous and mucocutaneous fungal infections | |
| Echinocandin antifungal | micafungin (IV) | Mycamine | Invasive candidiasis | |
| Glucocorticoid and azole antifungal | betamethasone and clotrimazole (topical) | Lotrisone | Cutaneous fungal infections | |
| Neuraminidase inhibitor antiviral | oseltamivir (PO) | Tamiflu | Influenza | |
| Antiviral | acyclovir (PO, IV) | Zovirax | Herpes simplex virus | |
| Antiviral | valacyclovir (PO) | Valtrex | Herpes simplex virus | |
| Antiviral | nirmatrelvir + ritonavir (PO) | Paxlovid | COVID-19 | |
| Antiviral | remdesivir (IV) | Veklury | COVID-19 | |
| Nucleoside/Nucleotide Reverse Transcriptase Inhibitor (NRTI) | emtricitabine + tenofovir disoproxil fumarate (PO) | Truvada | HIV Infection, PreP, PEP | |
| Nucleoside/Nucleotide Reverse Transcriptase Inhibitor (NRTI) and Integrase strand transfer inhibitor (INSTI) | emtricitabine (NRTI) + tenofovir alafenamide (NRTI) + bictegravir (INSTRI) (PO) | Biktarvy | HIV infection | |
| Opioid analgesic | fentanyl (transdermal, IV) | Transdermal: Duragesic IV: Sublimaze | CS-II | Pain |
| Opioid analgesic | hydromorphone (PO, IV) | Dilaudid | CS-II | Pain |
| Opioid analgesic | morphine (extended release)(PO) | MS Contin, Kadian | CS-II | Pain |
| Opioid analgesic | morphine (immediate release)(PO, IV, IM, PR) | IV: Duramorph, Influmorph | CS-II | Pain |
| Opioid analgesic | oxycodone (PO) | OxyContin, Roxicodone | CS-II | Pain |
| Opioid analgesic | methadone (PO, IV) | Dolophine | CS-II | Opioid use disorder, severe chronic pain |
| Analgesic (non-opioid), antipyretic | acetaminophen (PO, PR, IV) | PO/PR: Tylenol IV: Ofirmev | PO, PR: OTC | Pain, fever |
| Central analgesic: partial opioid agonist | tramadol (PO) | Ultram, Ultram Er | CS-IV | Pain |
| Opioid and nonopioid analgesic combination | hydrocodone and acetaminophen (PO) | Lortab, Vicodin, Norco | CS-II | Pain |
| Opioid and nonopioid analgesic combination | oxycodone and acetaminophen (PO) | Percocet, Endocet | CS-II | Pain |
| Opioid and nonopioid analgesic combination | codeine and acetaminophen (PO) | Tylenol with Codeine #3, Tylenol with Codeine #4 | CS-III | Pain |
| Opioid antagonist | naloxone (IV, IM, SQ, intranasal) | Narcan Nasal Spray, Zimhi | OTC: Narcan Nasal Spray | Opioid overdose |
| Partial opioid agonist and opioid antagonist | buprenorphine and naloxone (SL) | Suboxone | CS-III | Opioid use disorder |
| Iron Supplement | ferrous sulfate (PO) | FeroSul, SlowFe | OTC | Iron deficiency anemia |
| Water-soluble vitamin | cyanocobalamin (vitamin B12)(PO, IM, SL, intranasal) | --- | OTC: PO, SL | Vitamin B12 deficiency (manifests as macrocytic anemia) |
| Water-soluble vitamin | folic acid (PO) | --- | OTC | Folic acid deficiency (manifests as macrocytic anemia), prevention of neural tube defects in pregnancy |
| Antimetabolite (folic acid antagonist) | methotrexate (PO, IV, IT) | Trexall | Rheumatoid arthritis, Crohn's Disease, psoriasis, various hematologic and solid tumors | |
| Antineoplastic agent, platinum-based compound | cisplatin (IV, IT, IP) | Kemoplat | Advanced bladder, ovarian, and testicular cancer; various cancers | |
| Antineoplastic agent, anthacycline | doxorubicin | Adriamycin | Adjuvant therapy for breast cancer, various cancers | |
| Antineoplastic agent, monoclonal antibody | pembrolizumab (IV) | Keytruda | various cancers | |
| Aromatase inhibitor | anastrozole (PO) | Arimidex | Hormone receptor-positive breast cancer | |
| Selective estrogen receptor modulator (SERM) | tamoxifen (PO) | Soltamox | Hormone receptor-positive breast cancer |